PYXS
Pyxis OncologyยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PYXS Profile
Pyxis Oncology, Inc.
A diversified oncology company focused on developing therapeutics to target difficult-to-treat cancers
321 Harrison Avenue, Boston, Massachusetts 02118
--
Pyxis Oncology, Inc., was incorporated in Delaware on June 11, 2018. The company is a clinical-stage oncology company focused on developing a multi-modal portfolio of next-generation therapies to target difficult-to-treat cancers and improve the quality of life of patients. The goal of the product candidates developed by the company is to directly kill tumor cells and address the underlying pathology caused by cancer, resulting in uncontrolled proliferation and immune evasion.
